Literature DB >> 31741857

Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes.

Liang Liang1,2, Meng-Nan Zhu1,2,3, Bao-Ji Chen1,2, Zheng Wang1,2, Li-Ye He1,2, Rang Zhang1,2.   

Abstract

AIM: To study the inhibition effect of TAK-242 on the proliferation of rat eye Tenon's capsule fibroblasts via the toll-like receptor 4 (TLR4) signaling pathway.
METHODS: SD rat Tenon's capsule fibroblasts were extracted and cultured, then the cells were divided into normal control group, lipopolysaccharide (LPS) group (10 g/mL LPS) and TAK-242 group (1 µmol/L TAK-242, and 10 µg/mL LPS after 30min). The expressions of TLR4, transforming growth factor-β1 (TGF-β1) and interleukin-6 (IL-6) in each group were detected by Western blot and reverse transcriptase-polymerase chain reaction (RT-PCR). Cell proliferation was detected by cell counting kit-8 (CCK-8).
RESULTS: Double immunofluorescent labeling in the extracted cells showed negative keratin staining and positive vimentin staining. Western blot showed that the LPS group had the highest expression of TLR4 and TGF-β1 (P<0.01). Enzyme linked immunosorbent assay (ELISA) also showed that the secretion of IL-6 was the highest in LPS group (P<0.01). But there was no significant difference in TLR4 and TGF-1, as well as IL-6 expressions between the TAK-242 group and the normal control group (P>0.05). RT-PCR showed that the IL-6 mRNA expression in LPS group was the highest in the three groups (P<0.01).
CONCLUSION: TAK-242 inhibits the proliferation of LPS-induced Tenon's capsule fibroblasts and the release of inflammatory factors by regulating the TLR4 signaling pathway, providing a new idea for reducing the scarring of the filter passage after glaucoma filtration surgery. International Journal of Ophthalmology Press.

Entities:  

Keywords:  TAK-242; Tenon's capsule fibroblasts; fibrosis; rat

Year:  2019        PMID: 31741857      PMCID: PMC6848881          DOI: 10.18240/ijo.2019.11.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  36 in total

1.  A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.

Authors:  Masayuki Ii; Naoko Matsunaga; Kaoru Hazeki; Kazuyo Nakamura; Katsunori Takashima; Tsukasa Seya; Osamu Hazeki; Tomoyuki Kitazaki; Yuji Iizawa
Journal:  Mol Pharmacol       Date:  2005-12-22       Impact factor: 4.436

2.  Simplified quantitation of myeloid dendritic cells in peripheral blood using flow cytometry.

Authors:  J W Upham; J Lundahl; H Liang; J A Denburg; P M O'Byrne; D P Snider
Journal:  Cytometry       Date:  2000-05-01

Review 3.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2011-03-11       Impact factor: 53.106

Review 4.  Role of transforming growth factor beta in conjunctival scarring.

Authors:  M Francesca Cordeiro
Journal:  Clin Sci (Lond)       Date:  2003-02       Impact factor: 6.124

5.  FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.

Authors:  Swati Bhattacharyya; Zenshiro Tamaki; Wenxia Wang; Monique Hinchcliff; Paul Hoover; Spiro Getsios; Eric S White; John Varga
Journal:  Sci Transl Med       Date:  2014-04-16       Impact factor: 17.956

Review 6.  LPS/TLR4 signal transduction pathway.

Authors:  Yong-Chen Lu; Wen-Chen Yeh; Pamela S Ohashi
Journal:  Cytokine       Date:  2008-03-04       Impact factor: 3.861

7.  Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis.

Authors:  Giuseppina Stifano; Alsya J Affandi; Allison L Mathes; Lisa M Rice; Sashidhar Nakerakanti; Banafsheh Nazari; Jungeun Lee; Romy B Christmann; Robert Lafyatis
Journal:  Arthritis Res Ther       Date:  2014-07-01       Impact factor: 5.156

8.  Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts.

Authors:  Yang Liu; Kazuhiro Kimura; Tomoko Orita; Katsuyoshi Suzuki; Shinichiro Teranishi; Takuya Mori; Koh-Hei Sonoda
Journal:  Mol Vis       Date:  2015-12-31       Impact factor: 2.367

Review 9.  Innovations in glaucoma surgery from Dr. Rajendra Prasad Centre for Ophthalmic Sciences.

Authors:  Tanuj Dada; Neha Midha; Pooja Shah; Talvir Sidhu; Dewang Angmo; Ramanjit Sihota
Journal:  Indian J Ophthalmol       Date:  2017-02       Impact factor: 1.848

10.  TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury.

Authors:  Yide Zhang; Weisheng Peng; Xiang Ao; Houyong Dai; Li Yuan; Xinzhong Huang; Qiaoling Zhou
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.